Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells-Reference-Cited by-同舟云学术

Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells

Published:2014-08-06 Issue:9 Volume:106 Page:308-322
ISSN:0248-4900
Container-title:Biology of the Cell
language:en
Short-container-title:Biol. Cell

Author:

Rosso Marina¹,Lapyckyj Lara¹,Amiano Nicolás²,Besso María José¹,Sánchez Mercedes²,Chuluyan Eduardo²,Vazquez-Levin Mónica Hebe¹

Affiliation:

1. Instituto de Biología & Medicina Experimental (IBYME); National Research Council of Argentina (CONICET); Vuelta de Obligado 2490 Buenos Aires C1428ADN Argentina

2. 3a. Cátedra de Farmacología, Facultad de Medicina; Universidad de Buenos Aires; 9° Piso, Paraguay 2155 Buenos Aires C1121ABG Argentina

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/boc.201300075/fullpdf

Reference39 articles.

1. Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells;Akasaka;BMC Cancer,2010

2. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma;Alonso;J. Surg. Oncol.,1996

3. Anti-tumor effect of SLPI on mammary but not colon tumor growth;Amiano;J. Cell Physiol.,2013

4. Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth;Amiano;Cancer Immunol. Immunother.,2011

5. The cadherin superfamily;Angst;J. Cell Sci.,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications;Heliyon;2024-01

2. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications;Pathology - Research and Practice;2023-08

3. Inhibition of secretory leukocyte protease inhibitor (SLPI) promotes the PUMA-mediated apoptosis and chemosensitivity to cisplatin in colorectal cancer cells;Discover Oncology;2023-01-03

4. Association of MARCH7 with tumor progression and T-cell infiltration in esophageal cancer;Medical Oncology;2022-12-30

5. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence;Scientific Reports;2022-07-16